Nurturing And Supporting Healthy Babies Act

Bill: 114-hr-4978
Sponsor: Rep. Jenkins, Evan H. [R-WV-3]
Introduced: 2016-04-18 in the House
Policy area: Health
Subjects: Child health
Congressional oversight
Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Fraud offenses and financial crimes
Freedom of information
Government information and archives
Government studies and investigations
Health care costs and insurance
Health care coverage and access
Health information and medical records
Health programs administration and funding
Medicaid
Medicare
Prescription drugs
Public contracts and procurement

Summary:
action_date: 2016-04-18
text: 

Nurturing and Supporting Healthy Babies Act or the NAS Healthy Babies Act

 
This bill requires the Government Accountability Office (GAO) to report on neonatal abstinence syndrome (NAS), which results from a newborn's exposure to addictive opiate drugs while in the mother's womb.
 
Specifically, the GAO shall report on:
 
 
the prevalence of NAS,
 
NAS treatment services for which coverage is available under state Medicaid programs,
 
the settings and associated reimbursement methodologies for NAS treatment,
 
the prevalence of utilization of various care settings under state Medicaid programs for NAS treatment, and
 
any federal barriers to treating infants with NAS under state Medicaid programs.

 
The GAO shall also report on its recommendations for improvements that will ensure access to NAS treatment under state Medicaid programs.

action_date: 2016-05-10
text: 

Nurturing and Supporting Healthy Babies Act or the NAS Healthy Babies Act

 
(Sec. 2) This bill requires the Government Accountability Office (GAO) to report on neonatal abstinence syndrome (NAS), which results from a newborn's exposure to addictive opiate drugs while in the mother's womb.
 
Specifically, the GAO shall report on:
 
 
the prevalence of NAS, 
 
NAS treatment services for which coverage is available under state Medicaid programs, 
 
the settings and associated reimbursement methodologies for NAS treatment, 
 
the prevalence of utilization of various care settings under state Medicaid programs for NAS treatment, and 
 
any federal barriers to treating infants with NAS under state Medicaid programs.

 
The GAO shall also report on its recommendations for improvements that will ensure access to NAS treatment under state Medicaid programs.
 
(Sec. 3) The bill amends title XIX (Medicaid) of the Social Security Act to exclude abuse-deterrent formulations of prescription drugs from the requirement that manufacturers of single-source or innovator drugs pay additional rebates to state Medicaid programs.
 
(Sec. 4) Under current law, the Centers for Medicare & Medicaid Services (CMS) must use predictive modeling and other analytic technologies to identify improper Medicaid claims. The bill prohibits a state agency from using or disclosing such technologies except for purposes of administering a state Medicaid program or Children's Health Insurance Program. A state agency shall have in effect adequate data security and control policies to ensure that access to such information is restricted to authorized persons for authorized uses.
 
(Sec. 5) The bill places $5 million in the Medicaid Improvement Fund to be available beginning in FY2021.

action_date: 2016-05-11
text: 

Nurturing and Supporting Healthy Babies Act or the NAS Healthy Babies Act

 
(Sec. 2) This bill requires the Government Accountability Office (GAO) to report on neonatal abstinence syndrome (NAS), which results from a newborn's exposure to addictive opiate drugs while in the mother's womb.
 
Specifically, the GAO shall report on:
 
 
the prevalence of NAS, 
 
NAS treatment services for which coverage is available under state Medicaid programs, 
 
the settings and associated reimbursement methodologies for NAS treatment, 
 
the prevalence of utilization of various care settings under state Medicaid programs for NAS treatment, 
 
any federal barriers to treating infants with NAS under state Medicaid programs, and
 
best practices for treating infants with NAS.

 
The GAO shall also report on its recommendations for improvements that will ensure access to NAS treatment under state Medicaid programs.
 
(Sec. 3) The bill amends title XIX (Medicaid) of the Social Security Act to exclude abuse-deterrent formulations of prescription drugs from the requirement that manufacturers of single-source or innovator drugs pay additional rebates to state Medicaid programs.
 
(Sec. 4) Under current law, the Centers for Medicare & Medicaid Services (CMS) must use predictive modeling and other analytic technologies to identify improper Medicaid claims. The bill prohibits a state agency from using or disclosing such technologies except for purposes of administering a state Medicaid program or Children's Health Insurance Program. A state agency shall have in effect adequate data security and control policies to ensure that access to such information is restricted to authorized persons for authorized uses.
 
(Sec. 5) The bill places $5 million in the Medicaid Improvement Fund to be available beginning in FY2021.


Legislative actions:
action_date: 2016-05-12
text: Received in the Senate and Read twice and referred to the Committee on Finance.
action_date: 2016-05-11
text: The title of the measure was amended. Agreed to without objection.
action_date: 2016-05-11
text: Motion to reconsider laid on the table Agreed to without objection.
action_date: 2016-05-11
text: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H2259-2260)
action_date: 2016-05-11
text: Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H2259-2260)
action_date: 2016-05-11
text: DEBATE - The House proceeded with forty minutes of debate on H.R. 4978.
action_date: 2016-05-11
text: Considered under suspension of the rules. (consideration: CR H2259-2263)
action_date: 2016-05-11
text: Mr. Guthrie moved to suspend the rules and pass the bill, as amended.
action_date: 2016-05-10
text: Placed on the Union Calendar, Calendar No. 433.
action_date: 2016-05-10
text: Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 114-559.
action_date: 2016-05-10
text: Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 114-559.
action_date: 2016-04-27
text: Ordered to be Reported (Amended) by Voice Vote.
action_date: 2016-04-27
text: Committee Consideration and Mark-up Session Held.
action_date: 2016-04-26
text: Committee Consideration and Mark-up Session Held.
action_date: 2016-04-25
text: Committee Consideration and Mark-up Session Held.
action_date: 2016-04-20
text: Forwarded by Subcommittee to Full Committee by Voice Vote .
action_date: 2016-04-20
text: Subcommittee Consideration and Mark-up Session Held.
action_date: 2016-04-18
text: Referred to the Subcommittee on Health.
action_date: 2016-04-18
text: Referred to the House Committee on Energy and Commerce.
action_date: 2016-04-18
text: Introduced in House
action_date: 2016-04-18
text: Introduced in House